InvestorsObserver
Sign Up Login

APLT Applied Therapeutics Inc

$0.99 $0.03 (3.17%)
Add to Watchlist Compare
Overall

APLT Stock Analysis Overview

What this means: InvestorsObserver gives Applied Therapeutics Inc (APLT) an overall rank of 47, which is below average. Applied Therapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 47 means that 53% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

APLT Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

APLT Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

APLT Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

APLT Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

APLT Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

APLT Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

APLT Stock Analysis Overview

What this means: InvestorsObserver gives Applied Therapeutics Inc (APLT) an overall rank of 47, which is below average. Applied Therapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 47 means that 53% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full APLT report

APLT Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

APLT Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

APLT Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

APLT Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

APLT Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

APLT Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Applied Therapeutics Inc (APLT) Analyst Forecast

APLT Price, Volume, Earnings, and Dividend Date

  • Last Price $0.99
  • Previous Close $0.96
  • Change $0.03
  • Open $0.96
  • Volume 18,318
  • Avg. Volume (100-day) 366,099
  • Market Cap 47,540,505
  • Days Range 0.9612 - 0.9999
  • 52-week Range 0.73 - 19.14
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS —
  • Earnings Date 11/11/22
  • Sector Healthcare
  • Industry Biotechnology
  • Avg. Analyst Rec. Premium
  • Beta 0.576
  • PEG Ratio —

Applied Therapeutics Inc (APLT) Company Description

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.

Applied Therapeutics Inc (APLT) Stock Chart

View Interactive APLT chart

My Watchlists

Follow Your Favorite Stocks

Top Stocks in Biotechnology

Company Price
Ardelyx Inc (ARDX) (ARDX) $1.39
Liquidia Corp (LQDA) (LQDA) $5.64
Minerva Neuroscie (NERV) (NERV) $9.84
Axsome Thera (AXSM) (AXSM) $46.28
Satsuma Pharmaceuticals Inc (STSA) (STSA) $5.71
Pliant Therapeutics Inc (PLRX) (PLRX) $21.81
G1 Therapeutics Inc (GTHX) (GTHX) $12.45
Fireman B.V. (IFRX) (IFRX) $2.66
Logicbio Therapeutics Inc (LOGC) (LOGC) $2.01
Wave Life Sci Ord Sh (WVE) (WVE) $3.54